Target Price | $4.00 |
Price | $1.02 |
Potential |
292.16%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Second Sight Medical Products, Inc. 2026 .
The average Second Sight Medical Products, Inc. target price is $4.00.
This is
292.16%
register free of charge
$4.00
292.16%
register free of charge
$4.00
292.16%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Second Sight Medical Products, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Second Sight Medical Products, Inc. stock has an average upside potential 2026 of
292.16%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.43 | -0.42 |
14.00% | 2.33% | |
P/E | negative |
1 Analysts have issued a Second Sight Medical Products, Inc. forecast for earnings per share. The average Second Sight Medical Products, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Second Sight Medical Products, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 04 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 04 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 26 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 13 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 07 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.